These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments. Zhu H; Wang G; Zhu H; Xu A J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638 [No Abstract] [Full Text] [Related]
25. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma. Guo L; Li X; Liu R; Chen Y; Ren C; Du S Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817 [TBL] [Abstract][Full Text] [Related]
26. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407 [TBL] [Abstract][Full Text] [Related]
27. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma. Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071 [TBL] [Abstract][Full Text] [Related]
28. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma. Chen S; Lu Z; Chen X; Wu X; Tu H; Yu L; Xiao Z Oncol Lett; 2020 Nov; 20(5):147. PubMed ID: 32934715 [TBL] [Abstract][Full Text] [Related]
29. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis. He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P Front Oncol; 2021; 11():639600. PubMed ID: 33968738 [TBL] [Abstract][Full Text] [Related]
30. Overexpressed BSG related to the progression of lung adenocarcinoma with high-throughput data-mining, immunohistochemistry, Huang WT; Yang X; He RQ; Ma J; Hu XH; Mo WJ; Chen G Am J Transl Res; 2019; 11(8):4835-4850. PubMed ID: 31497203 [TBL] [Abstract][Full Text] [Related]
31. Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma. Wang G; Zhong Y; Liang J; Li Z; Ye Y PeerJ; 2020; 8():e8625. PubMed ID: 32117639 [TBL] [Abstract][Full Text] [Related]
32. Methylation Regulation of Li A; Wu H; Tian Q; Zhang Y; Zhang Z; Zhang X Front Oncol; 2021; 11():620200. PubMed ID: 34094905 [TBL] [Abstract][Full Text] [Related]
33. Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling. Horigome E; Fujieda M; Handa T; Katayama A; Ito M; Ichihara A; Tanaka D; Gombodorj N; Yoshiyama S; Yamane A; Yamada K; Horiguchi J; Shinozuka K; Oyama T; Nishiyama M; Rokudai S Oncotarget; 2018 Oct; 9(77):34554-34566. PubMed ID: 30349649 [TBL] [Abstract][Full Text] [Related]
34. The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction. Deng Y; He R; Zhang R; Gan B; Zhang Y; Chen G; Hu X Oncol Lett; 2018 Jun; 15(6):8556-8572. PubMed ID: 29805592 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma. Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F Front Oncol; 2021; 11():633420. PubMed ID: 33747955 [TBL] [Abstract][Full Text] [Related]
36. Function of low ADARB1 expression in lung adenocarcinoma. Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024 [TBL] [Abstract][Full Text] [Related]
37. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles. Uddin MN; Akter R; Li M; Abdelrahman Z Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520 [TBL] [Abstract][Full Text] [Related]
38. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma. Yu Y; Wang Z; Zheng Q; Li J Gene; 2021 Jul; 790():145689. PubMed ID: 33964375 [TBL] [Abstract][Full Text] [Related]
39. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma. Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269 [TBL] [Abstract][Full Text] [Related]
40. Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients. Shen E; Han Y; Cai C; Liu P; Chen Y; Gao L; Huang Q; Shen H; Zeng S; He M Aging (Albany NY); 2021 Mar; 13(5):7570-7588. PubMed ID: 33658393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]